{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/implementing-critical-infectious-disease-protocol#webpage",
"url": "https://www.fortrea.com/insights/implementing-critical-infectious-disease-protocol",
"name": "Implementing a critical infectious disease protocol",
"description": "This Fortrea case study explores the implementation of a complex infectious disease clinical trial protocol in intensive care unit (ICU) settings across multiple global regions. Conducting infectious disease clinical trials involving mechanically ventilated patients required careful coordination of patient recruitment, ethical consent processes, flexible staffing models, and integration with existing ICU workflows. The Phase I study spanned 18 sites across North America, Europe, and Asia-Pacific and presented operational challenges including 24/7 recruitment demands, customs and drug shipment delays, and high data management complexity. The case study highlights how Fortrea applied patient- and site-centric strategies, adaptive operational support, and close collaboration with investigators to improve enrollment performance and study execution while maintaining protocol compliance and data quality. By implementing flexible clinical operations, proactive site support, and tailored ICU trial management approaches, the program successfully advanced a critical infectious disease protocol in a highly complex research environment"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Implementing a critical infectious disease protocol",
"item": "https://www.fortrea.com/insights/implementing-critical-infectious-disease-protocol"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/implementing-critical-infectious-disease-protocol#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/implementing-critical-infectious-disease-protocol#webpage"
},
"headline": "Implementing a critical infectious disease protocol",
"description": "This Fortrea case study explores the implementation of a complex infectious disease clinical trial protocol in intensive care unit (ICU) settings across multiple global regions. Conducting infectious disease clinical trials involving mechanically ventilated patients required careful coordination of patient recruitment, ethical consent processes, flexible staffing models, and integration with existing ICU workflows. The Phase I study spanned 18 sites across North America, Europe, and Asia-Pacific and presented operational challenges including 24/7 recruitment demands, customs and drug shipment delays, and high data management complexity. The case study highlights how Fortrea applied patient- and site-centric strategies, adaptive operational support, and close collaboration with investigators to improve enrollment performance and study execution while maintaining protocol compliance and data quality. By implementing flexible clinical operations, proactive site support, and tailored ICU trial management approaches, the program successfully advanced a critical infectious disease protocol in a highly complex research environment",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/Implementing-a-critical-infectious-disease-protocol.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-01",
"dateModified": "2025-02-01",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/Implementing-a-critical-infectious-disease-protocol.pdf",
"encodingFormat": "application/pdf"
}
}
]
}